We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01991379
Recruitment Status : Recruiting
First Posted : November 25, 2013
Last Update Posted : March 5, 2018
Array BioPharma
University of Pittsburgh
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2021
  Estimated Study Completion Date : November 2021